Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q3)
Portfolio Summary: 70 holdings with a total value of $1,115,804,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HORIZON PHARMA PLC 5,503,182 99,773,000 8.94%
2 RETROPHIN INC COM 3,469,271 77,642,000 6.96%
3 NOVADAQ TECHNOLOGIES INC 5,174,209 59,866,000 5.37%
4 PROGENICS PHARMACEUTICALS IN 8,951,169 56,661,000 5.08%
5 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,394,464 54,491,000 4.88%
6 ANGIODYNAMICS INC 2,890,679 50,703,000 4.54%
7 HERON THERAPEUTICS INC 2,850,000 49,105,000 4.40%
8 LA JOLLA PHARMACEUTICAL CO 1,447,053 34,425,000 3.09%
9 SPDR SER TR 500,000 33,145,000 2.97% Put
10 ENDO INTL 1,454,538 29,309,000 2.63%
11 ARATANA THERAPEUTICS INC COM 3,085,979 28,885,000 2.59%
12 ANTARES PHARMA INC 14,885,393 25,007,000 2.24%
13 Lion Biotechnologies 2,638,259 21,713,000 1.95%
14 SOCIETAL CDMO INC 2,450,086 21,659,000 1.94%
15 ARALEZ PHARMACEUTICALS INC 4,406,990 21,374,000 1.92%
16 HORIZON PHARMA PLC 1,050,000 19,037,000 1.71% Call
17 OPHTHOTECH CORP COM 410,000 18,913,000 1.70%
18 MEDGENICS INC 3,370,306 18,773,000 1.68%
19 TELIGENT INC NEW 2,201,901 16,734,000 1.50%
20 ADVAXIS INC COM NEW 1,564,679 16,726,000 1.50%
21 IGNYTA INC COM 2,256,546 14,194,000 1.27%
22 DYNAVAX TECHNOLOGIES CORP 1,347,810 14,139,000 1.27%
23 BioDelivery Sciences International Inc 5,188,794 14,010,000 1.26%
24 TEVA PHARMACEUTICAL INDS LTD 300,000 13,803,000 1.24%
25 AEGERION PHARMACEUTICALS INC 4,361,291 12,953,000 1.16%
26 ACORDA THERAPEUTICS 604,700 12,626,000 1.13%
27 DERMA SCIENCES INC COM PAR .01 2,562,104 11,965,000 1.07%
28 SEASPINE HLDGS CORP COM 1,100,007 11,121,000 1.00%
29 QLT INC 5,269,831 10,856,000 0.97%
30 CORIUM INTERNATIONAL INC 1,919,721 10,808,000 0.97%
31 AMARIN CORP PLC 3,359,049 10,715,000 0.96%
32 ENDOLOGIX INC 800,000 10,240,000 0.92%
33 PARATEK PHARMACEUTICALS INC 786,134 10,228,000 0.92%
34 Intersect ENT Inc 638,600 10,115,000 0.91%
35 ZOGENIX INC 882,312 10,085,000 0.90%
36 Redhill Biopharma Ltd 717,203 9,962,000 0.89%
37 MEDICINES CO 255,600 9,646,000 0.86%
38 DEPOMED INC 379,474 9,475,000 0.85%
39 CATALYST PHARMACEUTICALS INC 8,200,000 8,938,000 0.80%
40 DURECT CORP 6,395,206 8,889,000 0.80%
41 EGALET CORP 10,000,000 8,781,000 0.79% PRN
42 Strongbridge Biopharma plc 1,656,706 8,648,000 0.78%
43 Egalet Corp 1,134,750 8,635,000 0.77%
44 ADMA BIOLOGICS, INC. 1,113,293 8,060,000 0.72%
45 AVIRAGEN THERAPEUTICS INC 3,486,711 6,694,000 0.60%
46 MIRATI THERAPEUTICS INC COM 1,000,000 6,610,000 0.59%
47 IDERA PHARMACEUTICALS INC 2,427,745 6,215,000 0.56%
48 RAPTOR PHARMACEUTICAL CORP 664,800 5,963,000 0.53%
49 SCYNEXIS INC 1,477,273 5,717,000 0.51%
50 CARDIOVASCULAR SYS INC DEL COM 230,532 5,473,000 0.49%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-016379, filed 2016.11.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.